Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingShort-Term Debt repayments
Ratios

bioAffinity Technologies (BIAF) Depreciation Expense (2022 - 2025)

Historic Depreciation Expense for bioAffinity Technologies (BIAF) over the last 4 years, with Q3 2025 value amounting to $44599.0.

  • bioAffinity Technologies' Depreciation Expense rose 1019.72% to $44599.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $175636.0, marking a year-over-year decrease of 3854.8%. This contributed to the annual value of $162332.0 for FY2024, which is 3034.87% down from last year.
  • Latest data reveals that bioAffinity Technologies reported Depreciation Expense of $44599.0 as of Q3 2025, which was up 1019.72% from $44468.0 recorded in Q2 2025.
  • In the past 5 years, bioAffinity Technologies' Depreciation Expense registered a high of $166284.0 during Q4 2023, and its lowest value of $800.0 during Q3 2022.
  • Moreover, its 4-year median value for Depreciation Expense was $40472.0 (2024), whereas its average is $42869.8.
  • In the last 5 years, bioAffinity Technologies' Depreciation Expense soared by 553687.5% in 2023 and then tumbled by 7425.73% in 2024.
  • Over the past 4 years, bioAffinity Technologies' Depreciation Expense (Quarter) stood at $7282.0 in 2022, then surged by 2183.49% to $166284.0 in 2023, then plummeted by 74.26% to $42806.0 in 2024, then increased by 4.19% to $44599.0 in 2025.
  • Its Depreciation Expense stands at $44599.0 for Q3 2025, versus $44468.0 for Q2 2025 and $43763.0 for Q1 2025.